{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T14:36:29Z","timestamp":1743086189951,"version":"3.40.3"},"publisher-location":"Singapore","reference-count":47,"publisher":"Springer Singapore","isbn-type":[{"type":"print","value":"9789811687013"},{"type":"electronic","value":"9789811687020"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-981-16-8702-0_12","type":"book-chapter","created":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T09:02:54Z","timestamp":1649754174000},"page":"199-205","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Entry Inhibitors of Hepatitis B and D Viruses"],"prefix":"10.1007","author":[{"given":"Yang","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youhua","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,13]]},"reference":[{"issue":"4","key":"12_CR1","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1002\/hep.24537","volume":"54","author":"A Baghdasaryan","year":"2011","unstructured":"Baghdasaryan A, Claudel T, Gumhold J, Silbert D, Adorini L, Roda A, Vecchiotti S, Gonzalez FJ, Schoonjans K, Strazzabosco M, Fickert P, Trauner M (2011) Dual farnesoid X receptor\/TGR5 agonist INT-767 reduces liver injury in the Mdr2\u2212\/\u2212 (Abcb4\u2212\/\u2212) mouse cholangiopathy model by promoting biliary HCO\u22123 output. Hepatology 54(4):1303\u20131312. https:\/\/doi.org\/10.1002\/hep.24537","journal-title":"Hepatology"},{"issue":"11","key":"12_CR2","doi-asserted-by":"publisher","first-page":"5841","DOI":"10.1128\/JVI.00096-07","volume":"81","author":"M Blanchet","year":"2007","unstructured":"Blanchet M, Sureau C (2007) Infectivity determinants of the hepatitis B virus pre-S domain are confined to the N-terminal 75 amino acid residues. J Virol 81(11):5841\u20135849. https:\/\/doi.org\/10.1128\/JVI.00096-07. Epub 2007 Mar 21","journal-title":"J Virol"},{"issue":"8","key":"12_CR3","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/nm0897-866","volume":"3","author":"Y Chen","year":"1997","unstructured":"Chen Y, Maguire T, Hileman RE, Fromm JR, Esko JD, Linhardt RJ, Marks RM (1997) Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat Med 3(8):866\u2013871. https:\/\/doi.org\/10.1038\/nm0897-866","journal-title":"Nat Med"},{"issue":"2","key":"12_CR4","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1517\/13543780802651583","volume":"18","author":"R Crabb\u00e9","year":"2009","unstructured":"Crabb\u00e9 R, Vuagniaux G, Dumont JM, Nicolas-M\u00e9tral V, Marfurt J, Novaroli L (2009) An evaluation of the cyclophilin inhibitor Debio 025 and its potential as a treatment for chronic hepatitis C. Expert Opin Investig Drugs 18(2):211\u2013220. https:\/\/doi.org\/10.1517\/13543780802651583","journal-title":"Expert Opin Investig Drugs"},{"issue":"1","key":"12_CR5","doi-asserted-by":"publisher","first-page":"15307","DOI":"10.1038\/s41598-017-15338-0","volume":"7","author":"JM Donkers","year":"2017","unstructured":"Donkers JM, Zehnder B, van Westen GJP, Kwakkenbos MJ, IJzerman AP, Oude Elferink RPJ, Beuers U, Urban S, van de Graaf SFJ (2017) Reduced hepatitis B and D viral entry using clinically applied drugs as novel inhibitors of the bile acid transporter NTCP. Sci Rep 7(1):15307. https:\/\/doi.org\/10.1038\/s41598-017-15338-0","journal-title":"Sci Rep"},{"issue":"5","key":"12_CR6","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/jmv.23549","volume":"85","author":"PE Florian","year":"2013","unstructured":"Florian PE, Macovei A, Lazar C, Milac AL, Sokolowska I, Darie CC, Evans RW, Roseanu A, Branza-Nichita N (2013) Characterization of the anti-HBV activity of HLP1-23, a human lactoferrin-derived peptide. J Med Virol 85(5):780\u2013788. https:\/\/doi.org\/10.1002\/jmv.23549","journal-title":"J Med Virol"},{"issue":"3","key":"12_CR7","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1128\/JVI.75.3.1565-1570.2001","volume":"75","author":"T Giroglou","year":"2001","unstructured":"Giroglou T, Florin L, Sch\u00e4fer F, Streeck RE, Sapp M (2001) Human papillomavirus infection requires cell surface heparan sulfate. J Virol 75(3):1565\u20131570. https:\/\/doi.org\/10.1128\/JVI.75.3.1565-1570.2001","journal-title":"J Virol"},{"issue":"5061","key":"12_CR8","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1126\/science.1598578","volume":"256","author":"JS Glenn","year":"1992","unstructured":"Glenn JS, Watson JA, Havel CM, White JM (1992) Identification of a prenylation site in delta virus large antigen. Science 256(5061):1331\u20131333. https:\/\/doi.org\/10.1126\/science.1598578","journal-title":"Science"},{"issue":"2","key":"12_CR9","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1006\/viro.1995.0002","volume":"213","author":"P Gripon","year":"1995","unstructured":"Gripon P, Le Seyec J, Rumin S, Guguen-Guillouzo C (1995) Myristylation of the hepatitis B virus large surface protein is essential for viral infectivity. Virology 213(2):292\u2013299. https:\/\/doi.org\/10.1006\/viro.1995.0002","journal-title":"Virology"},{"issue":"Pt 1","key":"12_CR10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1099\/vir.0.004861-0","volume":"90","author":"O Hantz","year":"2009","unstructured":"Hantz O, Parent R, Durantel D, Gripon P, Guguen-Guillouzo C, Zoulim F (2009) Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells. J Gen Virol 90(Pt 1):127\u2013135. https:\/\/doi.org\/10.1099\/vir.0.004861-0","journal-title":"J Gen Virol"},{"issue":"8","key":"12_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/cmi.13205","volume":"22","author":"C Herrscher","year":"2020","unstructured":"Herrscher C, Pastor F, Burlaud-Gaillard J, Dumans A, Seigneuret F, Moreau A, Patient R, Eymieux S, de Rocquigny H, Hourioux C, Roingeard P, Blanchard E (2020a) Hepatitis B virus entry into HepG2-NTCP cells requires clathrin-mediated endocytosis. Cell Microbiol 22(8):e13205. https:\/\/doi.org\/10.1111\/cmi.13205. Epub 2020 Apr 1","journal-title":"Cell Microbiol"},{"issue":"8","key":"12_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/cmi.13205","volume":"22","author":"C Herrscher","year":"2020","unstructured":"Herrscher C, Pastor F, Burlaud-Gaillard J, Dumans A, Seigneuret F, Moreau A, Patient R, Eymieux S, de Rocquigny H, Hourioux C, Roingeard P, Blanchard E (2020b) Hepatitis B virus entry into HepG2-NTCP cells requires clathrin-mediated endocytosis. Cell Microbiol 22(8):e13205. https:\/\/doi.org\/10.1111\/cmi.13205. Epub 2020 Apr 1","journal-title":"Cell Microbiol"},{"issue":"1","key":"12_CR13","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.virol.2003.09.014","volume":"318","author":"HJ Hong","year":"2004","unstructured":"Hong HJ, Ryu CJ, Hur H, Kim S, Oh HK, Oh MS, Park SY (2004) In vivo neutralization of hepatitis B virus infection by an anti-preS1 humanized antibody in chimpanzees. Virology 318(1):134\u2013141. https:\/\/doi.org\/10.1016\/j.virol.2003.09.014","journal-title":"Virology"},{"issue":"9","key":"12_CR14","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1136\/gutjnl-2015-310686","volume":"65","author":"HH Hu","year":"2016","unstructured":"Hu HH, Liu J, Lin YL, Luo WS, Chu YJ, Chang CL, Jen CL, Lee MH, Lu SN, Wang LY, You SL, Yang HI, Chen CJ, REVEAL-HBV Study Group (2016a) The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis B. Gut 65(9):1514\u20131521. https:\/\/doi.org\/10.1136\/gutjnl-2015-310686. Epub 2015 Dec 7. Erratum in: Gut. 2017 Sep;66(9):1730","journal-title":"Gut"},{"issue":"9","key":"12_CR15","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1136\/gutjnl-2015-310686","volume":"65","author":"HH Hu","year":"2016","unstructured":"Hu HH, Liu J, Lin YL, Luo WS, Chu YJ, Chang CL, Jen CL, Lee MH, Lu SN, Wang LY, You SL, Yang HI, Chen CJ, REVEAL-HBV Study Group (2016b) The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis B. Gut 65(9):1514\u20131521. https:\/\/doi.org\/10.1136\/gutjnl-2015-310686. Epub 2015 Dec 7. Erratum in: Gut. 2017 Sep;66(9):1730","journal-title":"Gut"},{"issue":"10","key":"12_CR16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3389\/fcimb.2020.00074","volume":"27","author":"Q Hu","year":"2020","unstructured":"Hu Q, Zhang F, Duan L, Wang B, Ye Y, Li P, Li D, Yang S, Zhou L, Chen W (2020) E-cadherin plays a role in hepatitis B virus entry through affecting glycosylated sodium-taurocholate cotransporting polypeptide distribution. Front Cell Infect Microbiol 27(10):74. https:\/\/doi.org\/10.3389\/fcimb.2020.00074","journal-title":"Front Cell Infect Microbiol"},{"issue":"17","key":"12_CR17","doi-asserted-by":"publisher","first-page":"8487","DOI":"10.1073\/pnas.1811064116","volume":"116","author":"M Iwamoto","year":"2019","unstructured":"Iwamoto M, Saso W, Sugiyama R, Ishii K, Ohki M, Nagamori S, Suzuki R, Aizaki H, Ryo A, Yun JH, Park SY, Ohtani N, Muramatsu M, Iwami S, Tanaka Y, Sureau C, Wakita T, Watashi K (2019) Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization. Proc Natl Acad Sci U S A 116(17):8487\u20138492. https:\/\/doi.org\/10.1073\/pnas.1811064116. Epub 2019 Apr 5","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"15","key":"12_CR18","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1007\/s40265-020-01400-1","volume":"80","author":"C Kang","year":"2020","unstructured":"Kang C, Syed YY (2020) Bulevirtide: first approval. Drugs 80(15):1601\u20131605. https:\/\/doi.org\/10.1007\/s40265-020-01400-1","journal-title":"Drugs"},{"issue":"34","key":"12_CR19","doi-asserted-by":"publisher","first-page":"56041","DOI":"10.18632\/oncotarget.10241","volume":"8","author":"J Kang","year":"2016","unstructured":"Kang J, Wang J, Cheng J, Cao Z, Chen R, Li H, Liu S, Chen X, Sui J, Lu F (2016) Down-regulation of NTCP expression by cyclin D1 in hepatitis B virus-related hepatocellular carcinoma has clinical significance. Oncotarget 8(34):56041\u201356050. https:\/\/doi.org\/10.18632\/oncotarget.10241","journal-title":"Oncotarget"},{"issue":"2","key":"12_CR20","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.jhep.2019.04.010","volume":"71","author":"A K\u00f6nig","year":"2019","unstructured":"K\u00f6nig A, Yang J, Jo E, Park KHP, Kim H, Than TT, Song X, Qi X, Dai X, Park S, Shum D, Ryu WS, Kim JH, Yoon SK, Park JY, Ahn SH, Han KH, Gerlich WH, Windisch MP (2019) Efficient long-term amplification of hepatitis B virus isolates after infection of slow proliferating HepG2-NTCP cells. J Hepatol 71(2):289\u2013300. https:\/\/doi.org\/10.1016\/j.jhep.2019.04.010. Epub 2019 May 8","journal-title":"J Hepatol"},{"issue":"11","key":"12_CR21","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1093\/infdis\/jis273","volume":"205","author":"M Krepstakies","year":"2012","unstructured":"Krepstakies M, Lucifora J, Nagel CH, Zeisel MB, Holstermann B, Hohenberg H, Kowalski I, Gutsmann T, Baumert TF, Brandenburg K, Hauber J, Protzer U (2012) A new class of synthetic peptide inhibitors blocks attachment and entry of human pathogenic viruses. J Infect Dis 205(11):1654\u20131664. https:\/\/doi.org\/10.1093\/infdis\/jis273. Epub 2012 Mar 28","journal-title":"J Infect Dis"},{"issue":"3","key":"12_CR22","doi-asserted-by":"publisher","first-page":"e58340","DOI":"10.1371\/journal.pone.0058340","volume":"8","author":"O Lamas Longarela","year":"2013","unstructured":"Lamas Longarela O, Schmidt TT, Sch\u00f6neweis K, Romeo R, Wedemeyer H, Urban S, Schulze A (2013) Proteoglycans act as cellular hepatitis delta virus attachment receptors. PLoS One 8(3):e58340. https:\/\/doi.org\/10.1371\/journal.pone.0058340. Epub 2013 Mar 7","journal-title":"PLoS One"},{"issue":"23","key":"12_CR23","doi-asserted-by":"publisher","first-page":"12443","DOI":"10.1128\/JVI.01594-09","volume":"83","author":"Y Le Duff","year":"2009","unstructured":"Le Duff Y, Blanchet M, Sureau C (2009) The pre-S1 and antigenic loop infectivity determinants of the hepatitis B virus envelope proteins are functionally independent. J Virol 83(23):12443\u201312451. https:\/\/doi.org\/10.1128\/JVI.01594-09. Epub 2009 Sep 16","journal-title":"J Virol"},{"issue":"1","key":"12_CR24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3390\/v13010097","volume":"13","author":"C Le","year":"2021","unstructured":"Le C, Sirajee R, Steenbergen R, Joyce MA, Addison WR, Tyrrell DL (2021) In vitro infection with hepatitis B virus using differentiated human serum culture of Huh7.5-NTCP cells without requiring dimethyl sulfoxide. Viruses 13(1):97. https:\/\/doi.org\/10.3390\/v13010097","journal-title":"Viruses"},{"issue":"6","key":"12_CR25","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.26738","volume":"26","author":"D Li","year":"2017","unstructured":"Li D, He W, Liu X, Zheng S, Qi Y, Li H, Mao F, Liu J, Sun Y, Pan L, Du K, Ye K, Li W, Sui J (2017) A potent human neutralizing antibody Fc-dependently reduces established HBV infections. Elife 26(6):e26738. https:\/\/doi.org\/10.7554\/eLife.26738","journal-title":"Elife"},{"key":"12_CR26","series-title":"Advances in experimental medicine and biology","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-13-9151-4_5","volume-title":"Hepatitis B virus infection","author":"F Li","year":"2020","unstructured":"Li F, Wang Z, Hu F, Su L (2020) Cell culture models and animal models for HBV study. In: Tang H (ed) Hepatitis B virus infection, Advances in experimental medicine and biology, vol 1179. Springer, Singapore. https:\/\/doi.org\/10.1007\/978-981-13-9151-4_5"},{"issue":"4","key":"12_CR27","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.jhep.2019.07.003","volume":"71","author":"A Loglio","year":"2019","unstructured":"Loglio A, Ferenci P, Uceda Renteria SC, Tham CYL, van B\u00f6mmel F, Borghi M, Holzmann H, Perbellini R, Trombetta E, Giovanelli S, Greco L, Porretti L, Prati D, Ceriotti F, Lunghi G, Bertoletti A, Lampertico P (2019) Excellent safety and effectiveness of high-dose myrcludex-B monotherapy administered for 48\u00a0weeks in HDV-related compensated cirrhosis: A case report of 3 patients. J Hepatol 71(4):834\u2013839. https:\/\/doi.org\/10.1016\/j.jhep.2019.07.003. Epub 2019 Jul 11","journal-title":"J Hepatol"},{"issue":"2","key":"12_CR28","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.antiviral.2012.12.008","volume":"97","author":"J Lucifora","year":"2013","unstructured":"Lucifora J, Esser K, Protzer U (2013) Ezetimibe blocks hepatitis B virus infection after virus uptake into hepatocytes. Antiviral Res 97(2):195\u2013197. https:\/\/doi.org\/10.1016\/j.antiviral.2012.12.008. Epub 2012 Dec 21","journal-title":"Antiviral Res"},{"issue":"1","key":"12_CR29","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1128\/JVI.01207-09","volume":"84","author":"A Macovei","year":"2010","unstructured":"Macovei A, Radulescu C, Lazar C, Petrescu S, Durantel D, Dwek RA, Zitzmann N, Nichita NB (2010) Hepatitis B virus requires intact caveolin-1 function for productive infection in HepaRG cells. J Virol 84(1):243\u2013253. https:\/\/doi.org\/10.1128\/JVI.01207-09","journal-title":"J Virol"},{"issue":"3","key":"12_CR30","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.jcmgh.2020.09.001","volume":"11","author":"F Mao","year":"2021","unstructured":"Mao F, Wang MX, Hou X, Zhou Z, Yan YY, Fang LJ, Tan Z, Fang WY, Liu T, He W, Li C, Xie XB, Lu SQ, Sui J, Wang F, Han J, Wang JS, Li W (2021) NTCP deficiency causes gallbladder abnormalities in mice and human beings. Cell Mol Gastroenterol Hepatol 11(3):831\u2013839. https:\/\/doi.org\/10.1016\/j.jcmgh.2020.09.001. Epub 2020 Sep 9","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"7","key":"12_CR31","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1111\/liv.14967","volume":"41","author":"C Masetti","year":"2021","unstructured":"Masetti C, Aghemo A (2021) Bulevirtide for treatment of patients with HDV infection and compensated cirrhosis: A (huge?) step in the right direction. Liver Int 41(7):1441\u20131442. https:\/\/doi.org\/10.1111\/liv.14967","journal-title":"Liver Int"},{"issue":"2","key":"12_CR32","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/hep.31308","volume":"73","author":"A Murayama","year":"2021","unstructured":"Murayama A, Yamada N, Osaki Y, Shiina M, Aly HH, Iwamoto M, Tsukuda S, Watashi K, Matsuda M, Suzuki R, Tanaka T, Moriishi K, Suzuki T, Nishitsuji H, Sugiyama M, Mizokami M, Shimotohno K, Wakita T, Muramatsu M, Liang TJ, Kato T (2021) N-terminal PreS1 sequence regulates efficient infection of cell-culture-generated hepatitis B virus. Hepatology 73(2):520\u2013532. https:\/\/doi.org\/10.1002\/hep.31308. Epub 2020 Oct 31","journal-title":"Hepatology"},{"issue":"29","key":"12_CR33","doi-asserted-by":"publisher","first-page":"15870","DOI":"10.1002\/anie.202102717","volume":"60","author":"C Nie","year":"2021","unstructured":"Nie C, Pouyan P, Lauster D, Trimpert J, Kerkhoff Y, Szekeres GP, Wallert M, Block S, Sahoo AK, Dernedde J, Pagel K, Kaufer BB, Netz RR, Ballauff M, Haag R (2021) Polysulfates block SARS-CoV-2 uptake through electrostatic interactions*. Angew Chem Int Ed Engl 60(29):15870\u201315878. https:\/\/doi.org\/10.1002\/anie.202102717. Epub 2021 Jun 9","journal-title":"Angew Chem Int Ed Engl"},{"issue":"12","key":"12_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.687785","volume":"9","author":"G Ou","year":"2021","unstructured":"Ou G, He L, Wang L, Song J, Lai X, Tian X, Wang L, Zhang K, Zhang X, Deng J, Zhuang H, Xiang K, Li T (2021) The genotype (A to H) dependent N-terminal sequence of HBV large surface protein affects viral replication, secretion and infectivity. Front Microbiol 9(12):687785. https:\/\/doi.org\/10.3389\/fmicb.2021.687785","journal-title":"Front Microbiol"},{"issue":"4","key":"12_CR35","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1002\/hep.27608","volume":"61","author":"L Peng","year":"2015","unstructured":"Peng L, Zhao Q, Li Q, Li M, Li C, Xu T, Jing X, Zhu X, Wang Y, Li F, Liu R, Zhong C, Pan Q, Zeng B, Liao Q, Hu B, Hu ZX, Huang YS, Sham P, Liu J, Xu S, Wang J, Gao ZL, Wang Y (2015) The p.Ser267Phe variant in SLC10A1 is associated with resistance to chronic hepatitis B. Hepatology 61(4):1251\u20131260. https:\/\/doi.org\/10.1002\/hep.27608. Epub 2015 Feb 23","journal-title":"Hepatology"},{"issue":"7","key":"12_CR36","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a004952","volume":"3","author":"S Sarrazin","year":"2011","unstructured":"Sarrazin S, Lamanna WC, Esko JD (2011) Heparan sulfate proteoglycans. Cold Spring Harb Perspect Biol 3(7):a004952. https:\/\/doi.org\/10.1101\/cshperspect.a004952","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"4","key":"12_CR37","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1128\/JVI.01902-09","volume":"84","author":"A Schulze","year":"2010","unstructured":"Schulze A, Schieck A, Ni Y, Mier W, Urban S (2010) Fine mapping of pre-S sequence requirements for hepatitis B virus large envelope protein-mediated receptor interaction. J Virol 84(4):1989\u20132000. https:\/\/doi.org\/10.1128\/JVI.01902-09. Epub 2009 Dec 9","journal-title":"J Virol"},{"issue":"2","key":"12_CR38","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/hep.24707","volume":"55","author":"A Schulze","year":"2012","unstructured":"Schulze A, Mills K, Weiss TS, Urban S (2012) Hepatocyte polarization is essential for the productive entry of the hepatitis B virus. Hepatology 55(2):373\u2013383. https:\/\/doi.org\/10.1002\/hep.24707. Epub 2011 Dec 16","journal-title":"Hepatology"},{"issue":"18","key":"12_CR39","doi-asserted-by":"publisher","first-page":"4160","DOI":"10.1038\/sj.emboj.7601841","volume":"26","author":"S Seitz","year":"2007","unstructured":"Seitz S, Urban S, Antoni C, B\u00f6ttcher B (2007) Cryo-electron microscopy of hepatitis B virions reveals variability in envelope capsid interactions. EMBO J 26(18):4160\u20134167. https:\/\/doi.org\/10.1038\/sj.emboj.7601841. Epub 2007 Aug 30","journal-title":"EMBO J"},{"issue":"3","key":"12_CR40","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1002\/hep.26125","volume":"57","author":"C Sureau","year":"2013","unstructured":"Sureau C, Salisse J (2013a) A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus a-determinant. Hepatology 57(3):985\u2013994. https:\/\/doi.org\/10.1002\/hep.26125. Epub 2013 Feb 15","journal-title":"Hepatology"},{"issue":"3","key":"12_CR41","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1002\/hep.26125","volume":"57","author":"C Sureau","year":"2013","unstructured":"Sureau C, Salisse J (2013b) A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus a-determinant. Hepatology 57(3):985\u2013994. https:\/\/doi.org\/10.1002\/hep.26125. Epub 2013 Feb 15","journal-title":"Hepatology"},{"issue":"1","key":"12_CR42","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/hep.28013","volume":"63","author":"ER Verrier","year":"2016","unstructured":"Verrier ER, Colpitts CC, Bach C, Heydmann L, Weiss A, Renaud M, Durand SC, Habersetzer F, Durantel D, Abou-Jaoud\u00e9 G, L\u00f3pez Ledesma MM, Felmlee DJ, Soumillon M, Croonenborghs T, Pochet N, Nassal M, Schuster C, Brino L, Sureau C, Zeisel MB, Baumert TF (2016) A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses. Hepatology 63(1):35\u201348. https:\/\/doi.org\/10.1002\/hep.28013. Epub 2015 Oct 6","journal-title":"Hepatology"},{"issue":"7","key":"12_CR43","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.4014\/jmb.1703.03066","volume":"27","author":"J Wi","year":"2017","unstructured":"Wi J, Jeong MS, Hong HJ (2017) Construction and characterization of an anti-hepatitis B virus preS1 humanized antibody that binds to the essential receptor binding site. J Microbiol Biotechnol 27(7):1336\u20131344. https:\/\/doi.org\/10.4014\/jmb.1703.03066","journal-title":"J Microbiol Biotechnol"},{"issue":"1","key":"12_CR44","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.00049","volume":"13","author":"H Yan","year":"2012","unstructured":"Yan H, Zhong G, Xu G, He W, Jing Z, Gao Z, Huang Y, Qi Y, Peng B, Wang H, Fu L, Song M, Chen P, Gao W, Ren B, Sun Y, Cai T, Feng X, Sui J, Li W (2012) Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife 13(1):e00049. https:\/\/doi.org\/10.7554\/eLife.00049. Erratum in: Elife 2014;3:e05570","journal-title":"Elife"},{"issue":"1","key":"12_CR45","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1080\/22221751.2019.1625728","volume":"8","author":"Y Yan","year":"2019","unstructured":"Yan Y, Allweiss L, Yang D, Kang J, Wang J, Qian X, Zhang T, Liu H, Wang L, Liu S, Sui J, Chen X, Dandri M, Zhao J, Lu F (2019) Down-regulation of cell membrane localized NTCP expression in proliferating hepatocytes prevents hepatitis B virus infection. Emerg Microbes Infect 8(1):879\u2013894. https:\/\/doi.org\/10.1080\/22221751.2019.1625728","journal-title":"Emerg Microbes Infect"},{"issue":"6","key":"12_CR46","doi-asserted-by":"publisher","first-page":"29391","DOI":"10.1038\/srep29391","volume":"7","author":"X Ye","year":"2016","unstructured":"Ye X, Zhou M, He Y, Wan Y, Bai W, Tao S, Ren Y, Zhang X, Xu J, Liu J, Zhang J, Hu K, Xie Y (2016) Efficient inhibition of hepatitis B virus infection by a preS1-binding peptide. Sci Rep 7(6):29391. https:\/\/doi.org\/10.1038\/srep29391","journal-title":"Sci Rep"},{"issue":"4","key":"12_CR47","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1136\/gutjnl-2014-308964","volume":"65","author":"TY Zhang","year":"2016","unstructured":"Zhang TY, Yuan Q, Zhao JH, Zhang YL, Yuan LZ, Lan Y, Lo YC, Sun CP, Wu CR, Zhang JF, Zhang Y, Cao JL, Guo XR, Liu X, Mo XB, Luo WX, Cheng T, Chen YX, Tao MH, Shih JW, Zhao QJ, Zhang J, Chen PJ, Yuan YA, Xia NS (2016) Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen. Gut 65(4):658\u2013671. https:\/\/doi.org\/10.1136\/gutjnl-2014-308964. Epub 2015 Sep 30","journal-title":"Gut"}],"container-title":["Advances in Experimental Medicine and Biology","Virus Entry Inhibitors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-16-8702-0_12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T09:34:40Z","timestamp":1649756080000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-981-16-8702-0_12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9789811687013","9789811687020"],"references-count":47,"URL":"https:\/\/doi.org\/10.1007\/978-981-16-8702-0_12","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"13 April 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}